Balance Sheet
Accounts PayablesCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EUDA Health Holdings (EUDA) Other Non-Current Liabilities (2022 - 2025)

Historic Other Non-Current Liabilities for Health Holdings (EUDA) over the last 4 years, with Q2 2025 value amounting to $141480.0.

  • Health Holdings' Other Non-Current Liabilities fell 897.04% to $141480.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $141480.0, marking a year-over-year decrease of 897.04%. This contributed to the annual value of $128504.0 for FY2024, which is 7108.55% up from last year.
  • As of Q2 2025, Health Holdings' Other Non-Current Liabilities stood at $141480.0, which was down 897.04% from $128504.0 recorded in Q4 2024.
  • In the past 5 years, Health Holdings' Other Non-Current Liabilities registered a high of $1.7 million during Q1 2023, and its lowest value of $15015.0 during Q4 2022.
  • In the last 4 years, Health Holdings' Other Non-Current Liabilities had a median value of $137225.0 in 2023 and averaged $331502.3.
  • Per our database at Business Quant, Health Holdings' Other Non-Current Liabilities skyrocketed by 40023.98% in 2023 and then crashed by 897.04% in 2025.
  • Health Holdings' Other Non-Current Liabilities (Quarter) stood at $15015.0 in 2022, then surged by 400.24% to $75111.0 in 2023, then soared by 71.09% to $128504.0 in 2024, then grew by 10.1% to $141480.0 in 2025.
  • Its Other Non-Current Liabilities was $141480.0 in Q2 2025, compared to $128504.0 in Q4 2024 and $155422.0 in Q2 2024.